In our study, we found that in osimertinib-resistant NSCLC cells, the expression level of the EMT-related protein E-cadherin was lower than that in sensitive cells, while the expression level of ID1 and vimentin were higher than those in sensitive cells. The gene discussed is ID1; the disease is non-small cell lung carcinoma.